Form D — Advantage Life Sciences I Jan 2026 a Series of CGF2021 LLC
0002111949-26-000001 · filed 2026-04-24
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.1
- Total offering
- $250,000
- Total sold
- $250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Advantage Life Sciences I Jan 2026 a Series of CGF2021 LLC
- CIK
- 2111949
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 2093 PHILADELPHIA PIKE
CLAYMONT, DE 19703 - Phone
- (360) 946-0604
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
LLC Sydecar · DirectorClaymont, DE Find on LinkedIn ↗
-
Brett Sagan · Executive OfficerClaymont, DE Find on LinkedIn ↗
View original on SEC EDGAR.